Wilbanks G - Search Results

1

Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis.

Alexander-Sefre F, Salvesen HB, Ryan A, Singh N, Akslen LA, MacDonald N, Wilbanks G, Jacobs IJ. Alexander-Sefre F, et al. Among authors: wilbanks g. Gynecol Oncol. 2003 Oct;91(1):218-25. doi: 10.1016/s0090-8258(03)00505-5. Gynecol Oncol. 2003. PMID: 14529685

2

Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry.

Alexander-Sefre F, Singh N, Ayhan A, Salveson HB, Wilbanks G, Jacobs IJ. Alexander-Sefre F, et al. Among authors: wilbanks g. J Clin Pathol. 2003 Oct;56(10):786-8. doi: 10.1136/jcp.56.10.786. J Clin Pathol. 2003. PMID: 14514787 Free PMC article.

3

A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro.

Li NF, Wilbanks G, Balkwill F, Jacobs IJ, Dafou D, Gayther SA. Li NF, et al. Among authors: wilbanks g. Lab Invest. 2004 Jul;84(7):923-31. doi: 10.1038/labinvest.3700093. Lab Invest. 2004. PMID: 15077121 Free article.

4

Prognostic indicators of survival in advanced endometrial cancer.

Behbakht K, Yordan EL, Casey C, DeGeest K, Massad LS, Kirschner CV, Wilbanks GD. Behbakht K, et al. Among authors: wilbanks gd. Gynecol Oncol. 1994 Dec;55(3 Pt 1):363-7. doi: 10.1006/gyno.1994.1307. Gynecol Oncol. 1994. PMID: 7835775

5

Human ovarian surface epithelial cells immortalized with hTERT maintain functional pRb and p53 expression.

Li NF, Broad S, Lu YJ, Yang JS, Watson R, Hagemann T, Wilbanks G, Jacobs I, Balkwill F, Dafou D, Gayther SA. Li NF, et al. Among authors: wilbanks g. Cell Prolif. 2007 Oct;40(5):780-94. doi: 10.1111/j.1365-2184.2007.00462.x. Cell Prolif. 2007. PMID: 17877616 Free PMC article.

6

Tubal sterilization and risk of cancer of the endometrium.

Lacey JV Jr, Brinton LA, Mortel R, Berman ML, Wilbanks GD, Twiggs LB, Barrett RJ. Lacey JV Jr, et al. Among authors: wilbanks gd. Gynecol Oncol. 2000 Dec;79(3):482-4. doi: 10.1006/gyno.2000.5970. Gynecol Oncol. 2000. PMID: 11104624

7

IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy.

Han X, Wilbanks GD, Devaja O, Ruperelia V, Raju KS. Han X, et al. Among authors: wilbanks gd. Gynecol Oncol. 1999 Nov;75(2):198-210. doi: 10.1006/gyno.1999.5557. Gynecol Oncol. 1999. PMID: 10525372

8

Radiation therapy in primary carcinoma of the vagina.

Reddy S, Lee MS, Graham JE, Yordan EL, Phillips R, Saxena VS, Hendrickson FR, Wilbanks GD. Reddy S, et al. Among authors: wilbanks gd. Gynecol Oncol. 1987 Jan;26(1):19-24. doi: 10.1016/0090-8258(87)90067-9. Gynecol Oncol. 1987. PMID: 3792932

9

Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors.

Zelmanowicz A, Hildesheim A, Sherman ME, Sturgeon SR, Kurman RJ, Barrett RJ, Berman ML, Mortel R, Twiggs LB, Wilbanks GD, Brinton LA. Zelmanowicz A, et al. Among authors: wilbanks gd. Gynecol Oncol. 1998 Jun;69(3):253-7. doi: 10.1006/gyno.1998.4941. Gynecol Oncol. 1998. PMID: 9648597 Free article.

10

Smoking, obesity, and survival in squamous cell carcinoma of the vulva.

Kirschner CV, Yordan EL, De Geest K, Wilbanks GD. Kirschner CV, et al. Among authors: wilbanks gd. Gynecol Oncol. 1995 Jan;56(1):79-84. doi: 10.1006/gyno.1995.1013. Gynecol Oncol. 1995. PMID: 7821852

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters